{
    "code": "02023374",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023374",
    "time": "2020-02-25 13:07:00",
    "許可證字號": "衛署藥輸字第023374號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/01\/30",
    "發證日期": "91\/01\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202337409",
    "中文品名": "得安穩膜衣錠160毫克",
    "英文品名": "DIOVAN FILM-COATED TABLETS 160MG",
    "適應症": "治療成人和6-18 歲的兒童或青少年高血壓、心衰竭(NYHA 二到四級)、心肌梗塞後左心室功能異常。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "VALSARTAN",
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FES0106000  NOVARTIS FARMACEUTICA S.A.",
            "製造廠廠址": "RONDA DE SANTA MARIA, 158, 08210,BARBERA DEL VALLES, BARCELONA, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005100",
            "成分名稱": "VALSARTAN",
            "含量描述": "",
            "含量": "160.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淺黃橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "橢圓形",
        "標記一": "DX,DX",
        "標記二": "NVR"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02023374.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=436&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Diovan leaflet-108-10-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=035&Type=9"
        },
        {
            "title": "Diovan_TWI-140316_C (中文仿單)-105-06-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=033&Type=9"
        },
        {
            "title": "Diovan_TWI-140515_C (依公告刊載賦形劑，自行變更仿單)-104-09-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=034&Type=9"
        },
        {
            "title": "Diovan 160 mg _foil-108-10-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=007&Type=8"
        },
        {
            "title": "Diovan 160 mg _FB-108-10-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=006&Type=8"
        },
        {
            "title": "1109592_ST_12_BB_TW_p2_FB-108-04-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023374&Seq=005&Type=8"
        }
    ]
}